PO-1001 The effect of switching to carboplatin chemo-RT for cycle 2 in cisplatin-ineligible HNSCC patients. (August 2021) - Price, J.; Fornacon-Wood, I.; Thomson, D.; Lee, L.; Sykes, A.; Garcez, K.; Price, G.; McPartlin, A.